← Leaderboards
Brian E Vestal
National Jewish Health
$1,256,148
Attributed
$2,512,296
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $862.2K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,512,296 · 1
By mechanism
R01$2,512,296 · 1
Top collaborators
- Evans Fernandez4 shared
Most similar at National Jewish Health
Same institution · by research overlap
- Carl W White$29,966,481
- Lisa A Maier$11,952,941
- Monica Kraft$36,612,836
- Ivana V Yang$13,155,768
- Evette S Radisky$7,854,444
Others in their field
Other Emerging Leaders on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$58,784,651
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$41,535,815
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
ComplexAreaAcuteBiologicalBronchoscopyCaliforniaAntigensCessation Of LifeCharacteristicsChest Computed TomographyChicagoChronicChronic DiseaseClassificationClinicCause Of DeathClinical DataClinical ManagementClinical PhenotypeClinical RiskClinical TrialsCohortComplementComputers
Grant awards (4)
Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis$579,069
R01 · FY2023 · HL
Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis$342,944
R01 · FY2022 · HL
Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis$728,047
R01 · FY2021 · HL
Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis$862,236
R01 · FY2020 · HL